3D-Printed candy pills could make medicine fun for kids
NCT ID NCT07424495
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study will see if children and adolescents like chewable tablets made with a 3D printer. Researchers will test different flavors and sweetness levels to find the most acceptable ones. The goal is to create personalized, tasty medicines that kids will actually take, improving treatment adherence.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- placebo chewable tablets produced by 3D printing
- What this could lead to
- If successful, this could lead to more child-friendly, personalized medicines that are easier and safer for kids to take.
- What could go wrong
- This is an early observational study with only 100 participants, so results may not apply to all children. It uses placebo tablets, not real medicine.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 100 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Mar 2027
An estimate. Start dates often move.
- Expected to finish
-
Dec 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Children and adolescents receiving care at the Nutrition Outpatient Clinic of the Hospital da Criança de Brasília José Alencar.
- Ages
-
3 to 18 years
- Sex
-
Anyone
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Children and adolescents aged 3 to 18 years receiving care at the Nutrition Outpatient Clinic of the Hospital da Criança de Brasília José Alencar (HCB). * Written informed consent provided by the legal guardian through the signing of the Informed Consent Form (ICF). * Assent from the child or adolescent, when applicable, expressed through the signing of the Informed Assent Form (IAF). Exclusion Criteria: * Children or adolescents with dietary restrictions or known allergies to any component present in the formulations used in the study. * Children or adolescents with glucose-6-phosphate dehydrogenase (G6PD) deficiency. * Children or adolescents diagnosed with severe neurological, cognitive, or behavioral disorders that impair communication, comprehension, or response to the sensory scale. * Oral conditions, mucosal lesions, or dysphagia that prevent or significantly impair proper chewing or swallowing of the tablet (e.g., mucositis). * Refusal of the child/adolescent or legal guardian to participate in the study at any time, even after prior consent has been provided.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Palatability assessment of 3D-printed chewable tablets in children and adolescents are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.